Global CBD (Cannabidiol) Gummies Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Cannabidiol (CBD) is a chemical in the Cannabis sativa plant, also known as cannabis or hemp. The cannabinoids in CBD Gummies bind to receptors in the body, which help reduce stress. Growing prevalence of neurological diseases and increasing use of cannabis for the treatment of neurological disorders are key drivers for the growth of CBD (Cannabidiol) Gummies market. For instance, according to The Neurological Alliance UK's Neuro Numbers 2019 report- as of 2019, UK has an estimated 14.7 million neurological cases, which equates to 1 in 6 people suffering from one or more neurological condition. Also, as per the European Medicines Agency (EMA)- in September 2019, the European Medicines Agency (EMA) has approved GW Pharmaceutical's Cannabidiol oral solution, EPIDYOLEX. EPIDYOLEX is the first plant-derived cannabis-based medicine, approved by the European agency. Also, with the increasing demand for certified products by consumers and rising Psychiatric disorders, the adoption & demand for CBD (Cannabidiol) Gummies is likely to increase the market growth during the forecast period. However, strengthen government policies for CBD use impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global CBD (Cannabidiol) Gummies market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to legalization of cannabis for medical purpose in the region. Whereas, Europe is anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027. Factors such as increasing demand for the product from healthcare industry and favorable government policies would create lucrative growth prospects for the CBD (Cannabidiol) Gummies market across Asia-Pacific region.

Major market player included in this report are:

CV Sciences Inc

Dixie Brands

Reliva CBD

Sunday Scaries

Green Roads

Medix CBD

Hemp Bombs

PureKana

Diamond CBD

Premium Jane

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Concentration:

High

Low

By Distribution Channel:

Offline

Online

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global CBD (Cannabidiol) Gummies Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors